Page 267 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

11 PROCARBAZINE 223

BIBLIOGRAPHIE
ZELLER P., et al., Methylhydrazine derivatives, a new class of cytotoxic agents, Expe-
rentia, 1963, 19, 129-130.
BOLLAG W. et al., US Patent 3830840, 1974, Chem. Abstr., 1976, 84, 150385.
RUCKI R.J. et al., Analytical Profiles of Drug Substances, Florey K., ed., Academic Press
New York., 1976, 5, 403-427.
WEINKAM R.J., SHIBA D.A., Metabolic activation of procarbazine, Lite Sciences, 1978,
22, 937-946.
SHIBA D.A., WEINKAM R.J., Quantitative analysis of procarbazine, procarbazine meta-
bolites and chemical degradation products with application to pharmacokinetic stu-
dies, J. Chromatogr., 1982, 229, 397-407.
PROUGH R.A. et al., Major isozymes of rat liver microsomal cytochrome P-450 involved
in the N-oxidation of N-isopropyl-a-(2-methylazo)-p-toluamide, the azo derivative of
procarbazine, Cancer Research, 1984, 44, 543-548.
AVERBUCH S.D., Nonclassic alkylating agents in Cancer Chemotherapy: principles and
practice, CHABNER B.A. et COLLINS J.M., J.B. Lippincott Company, Philadelphia,
1990, Chapitre 12, 314-340.
FONG L.Y.Y. et al., DNA adduct dosimetry and DNA repairin rats and pigs given repeated
doses of procarbazine under conditions of carcinogenicity and human cancerchemo-
therapy respectively, Carcinogenesis, 1992, 13, 2153-2159.
HOLTA., CALLINGHAM B.A., Further studies on the ex vivo effects of procarbazine and
monomethylhydrazine on rat semicarbazine-sensitive amine oxidase and monoamine
oxidase activities, J. Pharm. Pharmacol., 1994, 47, 837-845.
6
SOULIOTIS V.L. et al., Comparative dosimetry of 0 -methylguanine in human and
rodents treated with procarbazine, Carcinogenesis, 1994, 15, 1675-1680.